Pharmacy services company CVS Caremark Corp. (NYSE: CVS) will pay $160 million for the Medicare prescription drug business of Health Net Inc. (NYSE: HNT). The plan currently claims 400,000 subscribers.
The acquisition follows the failure of Walgreen Co. (NYSE: WAG) to negotiate a new contract with Express Scripts Inc. (NASDAQ: ESRX). Express Scripts accounted for about $5.3 billion in Walgreen’s revenues last year.
Health Net’s Medicare prescription drug plan was a stand-alone unit of the company, and Health Net will continue to offer its own Medicare Advantage program. The acquisition is expected to close in the second quarter. Health Net expects to net about $140 million from the sale and plans to use the funds “in ways that will benefit Health Net stockholders,” according to the company’s CEO.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.